NetworkNewsBreaks – CytoDyn Inc. (CYDY) Interim CMO to Present at 11th Annual Conference on Stem Cell and Regenerative Medicine

CytoDyn Inc. (OTCQB: CYDY), a biotechnology company developing innovative treatments for multiple therapeutic indications, this morning announced that Richard G. Pestell, M.D., Ph.D., president of the Pennsylvania Cancer and Regenerative Medicine Research Center, distinguished professor at the Baruch S. Blumberg Institute and interim chief medical officer of CytoDyn, will deliver the keynote plenary speech at the 11th Annual Conference on Stem Cell and Regenerative Medicine in Helsinki, Finland. Pestell’s presentation, titled ‘Cancer stem cells, genetic drivers and therapeutic targeting via CCR5’, is scheduled to take place on Monday, October 15, from 10-11 am EEST. Pestell will present recent scientific evidence demonstrating the effectiveness of PRO 140 (leronlimab), which is shown to bind to CCR5 in human breast cancer, block CCR5 signaling induced by cytokines and block human breast cancer cell invasion.

To view the full press release, visit http://nnw.fm/SgzM0

About CytoDyn

CytoDyn is a biotechnology company developing innovative treatments for multiple therapeutic indications based on PRO 140 (leronlimab), a novel humanized monoclonal antibody targeting the CCR5 receptor. CCR5 plays a key role in the ability of HIV to enter and infect healthy T-cells.  The CCR5 receptor is also implicated in tumor metastasis and in immune-mediated illnesses such as graft-vs-host disease (GvHD) and NASH. CytoDyn has successfully completed a Phase 3 pivotal trial with PRO 140 in combination with standard anti-retroviral therapies in HIV-infected treatment-experienced patients. The Company plans to seek FDA approval for PRO 140 in combination therapy and plans to complete the filing of a Biological License Application (BLA) in the first quarter of 2019 for that indication. CytoDyn is also conducting a Phase 3 investigative trial with PRO 140 as a once-weekly monotherapy for HIV-infected patients, and plans to initiate a registration-directed study of PRO 140 monotherapy indication, which if successful, could support a label extension. Clinical results to date from multiple trials have shown that PRO 140 can significantly reduce viral burden in people infected with HIV with no reported drug-related serious adverse events (SAEs). Moreover, results from a Phase 2b clinical trial demonstrated that PRO 140 monotherapy can prevent viral escape in HIV-infected patients, with some patients on PRO 140 monotherapy remaining virally suppressed for more than four years. CytoDyn is also conducting a Phase 2 trial to evaluate PRO 140 for the prevention of GvHD and expects to initiate clinical trials with PRO 140 in metastatic triple-negative breast cancer in 2018. For more information, visit the company’s website at www.CytoDyn.com

More from NetworkNewsBreaks

NetworkNewsBreaks – FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Investee Adds Taxation Reporting Technology to its Proprietary Compliance Platform NetworkNewsBreaks – First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF) Announces Results of Independent Studies Supporting Restart of Canadian Refinery NetworkNewsBreaks – The Flowr Corporation (TSX.V: FLWR) Ships Initial Purchase Order from the NSLC

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire has received compensation from CytoDyn Inc. for providing certain investor relations, marketing and social media services, including the preparation of this report, and expects to receive additional compensation for such services in the future. This compensation includes a monthly program fee.

Latest News

Asian shares up on hopes that US, China will solve dispute

Oct 16, 2018

SINGAPORE — Asian markets were mostly higher on Tuesday, though Chinese benchmarks fell after the government reported inflation rose for the fourth straight month. KEEPING SCORE: Japan's benchmark Nikkei 225 added 0.3 percent to 22,317.06. The Kospi in South Korea recovered 0.1 percent to 2,145.71. Hong Kong's Hang Seng index, which has fallen 22 percent since early January, slipped another 0.2 percent to 25,396.19. The Shanghai Composite dropped 0.2 percent to 2,564.24. Australia's S&P/ASX 200 gained 0.4 percent to 5,859.20. Shares rose in Taiwan, and Indonesia but fell in Singapore and Thailand. WALL STREET: Technology companies skidded and misses in...

China trade surplus with US widens to record $34.1B

Oct 16, 2018

BEIJING — China's trade surplus with the United States widened to a record $34.1 billion in September as exports to the American market rose by 13 percent over a year earlier despite a worsening tariff war. Exports to the United States rose to $46.7 billion, down from August's 13.4 percent growth, customs data showed Friday. Imports of American goods increased 9 percent to $12.6 billion, down from 11.1 percent. Chinese exports to the United States have at least temporarily defied forecasts they would weaken after being hit by punitive tariffs of up to 25 percent in a fight over American...

Losses on Wall Street ripple through Asia; stocks slump

Oct 16, 2018

SINGAPORE — Asian markets were broadly lower on Thursday after Wall Street slumped on a heavy selling of technology and internet stocks. Japan's benchmark fell by an unusually wide margin of 3.9 percent and China's main index lost 4.3 percent. Markets in Hong Kong, South Korea, Australia and Southeast Asia recorded similar declines. Investors are wary of possible further U.S. interest rate hikes. That will raise the cost of corporate borrowing and could drag on economic growth. The U.S. Federal Reserve recently raised short-term interest rates for the third time this year, with one more expected before the year ends....

Australia mulls banning some immigrants from biggest cities

Oct 16, 2018

CANBERRA, Australia — Starting a new life in Australia might not come with views of the Sydney Opera House or surfing at the city's Bondi Beach with the government considering a ban on some immigrants from settling in big cities. Minister for Cities, Urban Infrastructure and Population Alan Tudge said Tuesday that his government wants to cut the number of immigrants moving to Sydney and Melbourne in a bid to reduce congestion in Australia's two biggest cities. Tudge said placing conditions on visas that force immigrants to stay in less popular centers for several years would increase the likelihood that...

China tech stocks Lenovo, ZTE tumble after chip hack report

Oct 16, 2018

HONG KONG — Chinese tech stocks Lenovo Group and ZTE Corp. tumbled in Hong Kong on Friday following a news report Chinese spies might have used chips supplied by another company to hack into U.S. computer systems. Lenovo shares closed down 15.1 percent while ZTE lost 11 percent. Bloomberg News cited unidentified U.S. officials as saying malicious chips were inserted into equipment supplied by Super Micro Computer Inc. to American companies and government agencies. Lenovo, with headquarters in Beijing and Research Triangle Park, North Carolina, is the biggest global manufacturer of personal computers and has a growing smartphone brand. "Super...

Sign up now!